James Bryant Howard (1942 – 2022)
James Bryant Howard, professor emeritus of biochemistry at the University of Minnesota School of Medicine, died unexpectedly on Feb. 13 in Cochiti Lake, New Mexico. He was 79.
Howard had had been a member of the American Society for Biochemistry and Molecular Biology for more than 40 years, and he served on the Journal of Biological Chemistry editorial board from 1986 to 1991.
Born April 25, 1942, in Indianapolis, Howard completed his Bachelor of Arts in chemistry from DePauw University in 1964 before heading west to graduate school at the University of California, Los Angeles. He received his Ph.D. in biological chemistry at UCLA in 1968 as one of Alex Glazer's first graduate students. Howard often said that the exciting environment for biochemistry at UCLA catalyzed his life-long passion for protein chemistry, structure and function.
After a postdoctoral position with Fred Carpenter at UC Berkeley, Howard joined the biochemistry faculty at the University of Minnesota School of Medicine in 1971, where he remained until becoming emeritus in 2002. Among his notable research accomplishments were his identification of the modified histidine in EF-2 that is the target of ADP-ribosylation by diphtheria toxin (with James Bodley), discovery of the alkylamine-sensitive thioester linkage in the active site of the a2-macroglobulin, and a broad series of studies on the nitrogenase proteins, including determining the Azotobacter vinelandii nitrogenase iron protein sequence, identification of the [4Fe:4S] cluster ligands, and characterizing cluster chelation and interconversion reactions.
A great believer in the importance of sabbaticals, Howard arranged to visit the Massachusetts Institute of Technology, Harvard, UC Davis and the National Institutes of Health through this mechanism. I first met him while he was on sabbatical with William Lipscomb at Harvard in 1980-81 to crystallize the nitrogenase iron protein. He convinced me of the significance of a structural approach to the study of nitrogenase that, beginning with my postdoc, started a 40-plus year collaboration.
Over the past two decades — until COVID-19 — this collaboration included annual visits by Jim Howard and his wife, Claralyn, to Pasadena, where I work at the California Institute of Technology. Beyond nitrogenase, Howard had a strong interest in geobiology and interacted extensively with the Caltech community in this area. After he became emeritus, the Howards moved to New Mexico, and his research interests included isolation and characterization of nitrogen-fixing autotrophs in his home lab from the year-round seeps in the surrounding mesas.
Howard was a true natural philosopher; he loved designing experiments, going over results, attending seminars and discussing what it meant to prove a result. His curiosity was infectious. He focused on the details of experimental design and enjoyed discussing with students and postdocs how to accurately quantitate protein concentration, the temperature dependence of pH, and the importance of ionic strength effects — topics that are typically considered trivial but disastrous consequences can result if they are overlooked. A natural skeptic, Howard had a high bar for being convinced, and there was no bigger satisfaction than getting with him to that point. Beyond science, he read extensively and loved jazz and art, cycling and sailing, the outdoors. He was a keen student of academia and the bigger issues of life and society.
Our thoughts go to Claralyn Howard; their daughter, Cathy, and her husband, Tony Grundhauser; granddaughters Emma and Lucy; and Jim’s sister Aleta Howard at this difficult time.
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.Learn more
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Opinions
Opinions highlights or most popular articles
Science will suffer
We wondered if laws targeting LGBTQIA+ rights were affecting the career decisions of our members. It wasn’t easy to get answers.
As microbiome science forges ahead, will some be left behind?
The FDA’s approval of the first fecal microbiota treatment was a watershed moment — and also a wakeup call.
Cystic fibrosis: current understanding and prospects
In observance of National Cystic Fibrosis Awareness Month, we talked with researcher Neil Bradbury.
Those who care and engage
Being an ASBMB fellow isn’t just about hanging around together; it’s about engaging with others and moving together into the unknown.
An uncharted journey
These excerpts take us from Ilga Winicov Harrington’s childhood in Latvia and a German labor camp to her Ph.D. at the University of Pennsylvania.
The ASBMB fellows program recognizes the many ways members make a difference in our community. The society bestows the honorific, but the truth is these folks leveled up a long time ago.